Prospective study of epidemiology and prognostic factors in community-acquired pneumonia

被引:43
作者
Gomez, J
Banos, V
Gomez, JR
Soto, MC
Munoz, L
Nunez, ML
Canteras, M
Valdes, M
机构
[1] UNIV MURCIA, FAC MED, DEPT PATOL & CLIN MED, MURCIA, SPAIN
[2] UNIV MURCIA, FAC MED, DEPT BIOESTADIST, MURCIA, SPAIN
关键词
D O I
10.1007/BF01709363
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Of 342 patients with community-acquired pneumonia, 100 were diagnosed etiologically. In these patients, disease epidemiology, prognostic factors, and influence of antibiotic treatment were analyzed prospectively. Fifty-two patients were treated with a broad-spectrum antibiotic (ceftriaxone), and 48 received a medium-spectrum antibiotic (cefuroxime); some patients in each group also received erythromycin. Streptococcus pneumoniae was the most frequently isolated microorganism (43%), followed by Chlamydia pneumoniae (21%), Haemophilus influenzae (19%), and Mycoplasma pneumoniae (11%). Factors significantly associated with increased mortality were initially critical or poor clinical condition, involvement of two or more lobules, and complications. Prior administration of antibiotics was predictive of penicillin and erythromycin resistance in Streptococcus pneumoniae, but had no effect on the course of the disease. Eight patients died, 89 were cured, and three had recurrences; there! was no significant difference in outcome between treatment groups, regardless of whether patients also received erythromycin. Increased knowledge of epidemiological, predictive, and prognostic factors can significantly improve early diagnosis of community-acquired pneumonia and facilitate the choice of appropriate antibiotic treatment, thereby helping to reduce morbidity and mortality.
引用
收藏
页码:556 / 560
页数:5
相关论文
共 32 条
  • [11] NEW AND EMERGING ETIOLOGIES FOR COMMUNITY-ACQUIRED PNEUMONIA WITH IMPLICATIONS FOR THERAPY - A PROSPECTIVE MULTICENTER STUDY OF 359 CASES
    FANG, GD
    FINE, M
    ORLOFF, J
    ARISUMI, D
    YU, VL
    KAPOOR, W
    GRAYSTON, JT
    WANG, SP
    KOHLER, R
    MUDER, RR
    YEE, YC
    RIHS, JD
    VICKERS, RM
    [J]. MEDICINE, 1990, 69 (05) : 307 - 316
  • [12] PREDICTING DEATH IN PATIENTS HOSPITALIZED FOR COMMUNITY-ACQUIRED PNEUMONIA
    FARR, BM
    SLOMAN, AJ
    FISCH, MJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) : 428 - 436
  • [13] PREDICTION OF MICROBIAL ETIOLOGY AT ADMISSION TO HOSPITAL FOR PNEUMONIA FROM THE PRESENTING CLINICAL-FEATURES
    FARR, BM
    KAISER, DL
    HARRISON, BDW
    CONNOLLY, CK
    [J]. THORAX, 1989, 44 (12) : 1031 - 1035
  • [14] Gaztelurrutia L, 1994, Enferm Infecc Microbiol Clin, V12, P17
  • [15] Clinical significance of pneumococcal bacteraemias in a general hospital: A prospective study 1989-1993
    Gomez, J
    Banos, V
    Gomez, JR
    Herrero, F
    Nunez, ML
    Canteras, M
    Valdes, M
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (06) : 1021 - 1030
  • [16] ANTIBIOTIC-RESISTANCE PATTERNS OF STREPTOCOCCUS-PNEUMONIAE, HAEMOPHILUS-INFLUENZAE AND MORAXELLA-CATARRHALIS - A PROSPECTIVE-STUDY IN MURCIA, SPAIN, 1983-1992
    GOMEZ, J
    RUIZGOMEZ, J
    HERNANDEZCARDONA, JL
    NUNEZ, ML
    CANTERAS, M
    VALDES, M
    [J]. CHEMOTHERAPY, 1994, 40 (05) : 299 - 303
  • [17] Gomez J, 1993, Enferm Infecc Microbiol Clin, V11, P214
  • [18] ANTIMICROBIAL SUSCEPTIBILITY AND THERAPY OF INFECTIONS CAUSED BY CHLAMYDIA-PNEUMONIAE
    HAMMERSCHLAG, MR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (09) : 1873 - 1878
  • [19] MANIFESTATIONS OF SEPSIS
    HARRIS, RL
    MUSHER, DM
    BLOOM, K
    GATHE, J
    RICE, L
    SUGARMAN, B
    WILLIAMS, TW
    YOUNG, EJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (11) : 1895 - 1906
  • [20] Hueston W J, 1994, J Am Board Fam Pract, V7, P95